Elucidating the precise pharmacological mechanism of action (MOA) of naturally developing compounds may be challenging. While Tarselli et al. (60) created the first de novo artificial pathway to conolidine and showcased this naturally occurring compound efficiently suppresses responses to both chemically induced and inflammation-derived pain, the pharmacologic goal accountable https://crossbookmark.com/story20717504/conoldine-alternative-natural-pain-relief-no-further-a-mystery